Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 20Prostatic Neoplasms 19Carcinoma, Hepatocellular 15Brain Neoplasms 12Breast Neoplasms 10Pancreatic Neoplasms 9Neoplasm Metastasis 9Lung Neoplasms 5Neoplasms 4Recurrence 3Colorectal Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neuroma, Acoustic 2NSCLC 2Liver Neoplasms 2Head and Neck Neoplasms 2Glioblastoma 2Esophageal Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer 1Stage IA - IB Non Small Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Spine Metastasis 1Spinal Neoplasms 1Spinal Bone Metastases 1Solid Tumor 1Sarcoma 1Rare Diseases 1Radiotherapy 1

Interventions

camrelizumab 3Radiosurgery 2sinoporphyrin sodium 1penpulimab 1pembrolizumab 1apatinib 1Tramadol 1S 1 (combination) 1Poly(ADP-ribose) Polymerase Inhibitors 1Photochemotherapy 1Pemetrexed 1Paclitaxel 1Morphine 1Injections 1Immune Checkpoint Inhibitors 1130-nm albumin-bound paclitaxel 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Parkinson Disease 4, Autosomal Dominant Lewy Body × Radiosurgery × Clear all
NCT05626569 2024-01-03

Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC

Sun Yat-sen University

Phase 2 Unknown
40 enrolled
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05915481 2023-06-23

SCARCE

Peking University Third Hospital

Phase 1/2 Unknown
60 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body

Data powered by HemOnc (CC BY 4.0) Colophon âš¡